Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIS
5201
DELISTED
Aris Water Solutions
ARIS
| $156K | ﹤0.01% |
18,479
-60,353
| -77% | -$519K |
|
5202
Digimarc Corp
DMRC
$169M
| $156K | ﹤0.01% |
4,306
+2,446
| +132% | +$77.5K |
|
|
EWCZ
5203
DELISTED
European Wax Center
EWCZ
| $156K | ﹤0.01% |
11,538
+5,670
| +97% | +$82.1K |
|
5204
Horizon Bancorp
HBNC
$1.06B
| $156K | ﹤0.01% |
10,833
+3,226
| +42% | +$36.4K |
|
|
SABA
5205
Saba Capital Income & Opportunities Fund II
SABA
$220M
| $156K | ﹤0.01% |
20,611
-9,469
| -31% | -$74.1K |
|
5206
Superior Group of Companies
SGC
$208M
| $156K | ﹤0.01% |
11,514
+1,082
| +10% | +$11.3K |
|
5207
Innovator US Equity Ultra Buffer ETF April
UAPR
$159M
| $156K | ﹤0.01% |
5,669
+5,041
| +803% | +$133K |
|
5208
Xperi
XPER
$329M
| $156K | ﹤0.01% |
14,205
+6,332
| +80% | +$61.1K |
|
|
AMK
5209
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $156K | ﹤0.01% |
5,218
+2,465
| +90% | +$63.2K |
|
|
GPGI
5210
GPGI Inc
GPGI
$3.7B
| $155K | ﹤0.01% |
34,479
+4,578
| +15% | +$21.4K |
|
5211
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$99M
| $155K | ﹤0.01% |
2,426
-321
| -12% | -$19.9K |
|
5212
PUT
Flowers Foods
FLO
$1.59B
| $155K | ﹤0.01% |
+6,900
| New | +$149K |
|
|
LEO
5213
BNY Mellon Strategic Municipals
LEO
$390M
| $155K | ﹤0.01% |
26,500
-1,000
| -4% | -$5.5K |
|
5214
Mach Natural Resources
MNR
$2.17B
| $155K | ﹤0.01% |
+9,368
| New | +$162K |
|
|
CMBT
5215
CMB.TECH NV
CMBT
$5B
| $155K | ﹤0.01% |
8,817
-6,901
| -44% | -$122K |
|
5216
AnaptysBio
ANAB
$1.73B
| $154K | ﹤0.01% |
7,180
+4,537
| +172% | +$78.3K |
|
|
SRTA
5217
Strata Critical Medical Inc
SRTA
$522M
| $154K | ﹤0.01% |
43,819
+13,240
| +43% | +$38K |
|
5218
Global X Emerging Markets ex-China ETF
EMM
$57M
| $154K | ﹤0.01% |
5,882
-411
| -7% | -$10.1K |
|
5219
Edgewise Therapeutics
EWTX
$4.8B
| $154K | ﹤0.01% |
14,084
+6,182
| +78% | +$43.4K |
|
5220
Columbia India Consumer ETF
INCO
$237M
| $154K | ﹤0.01% |
2,624
-110
| -4% | -$6.12K |
|
5221
Nurix Therapeutics
NRIX
$2.81B
| $154K | ﹤0.01% |
14,923
+6,816
| +84% | +$46.7K |
|
5222
RE/MAX Holdings
RMAX
$268M
| $154K | ﹤0.01% |
11,506
+589
| +5% | +$6.46K |
|
|
CNCR
5223
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
| $153K | ﹤0.01% |
11,361
+6,236
| +122% | +$68.1K |
|
5224
iShares MSCI China Small-Cap ETF
ECNS
$66.3M
| $153K | ﹤0.01% |
5,938
+704
| +13% | +$18.7K |
|
5225
Disc Medicine
IRON
$3.03B
| $153K | ﹤0.01% |
2,651
+1,522
| +135% | +$77.9K |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 467 new positions and adding to 4,112 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 467 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.